|
News
Notice of New Year Holidays
|
News
【Participation in the Singapore Week of Innovation & Technology (SWITCH) 2023】
|
News
【Announcement of Participation in the “Viet Nam – Japan Medical ICT and Aging Workshop” hosted by the Office of Healthcare Policy, Cabinet Secretariat, Government of Japan】
|
Media
Medmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTech
|
News
The Ambassador of the United Arab Emirates visited our office!
|
Media
Successful Development of Artificial Intelligence to Enable Classification of Cutaneous Melanoma in a Whole Slide Image of Dermatopathology ~ Published in Cancers
|
Media
Successful Development of Artificial Intelligence to Enable Detection of Prostate Cancer for Surveillance and Radical Treatment -Published in BMC Cancer-
|
Media
Successful Development of Artificial Intelligence to Infer Histological Views From Whole Slide Images and Generate Them Into Text – Published in Proceedings of Machine Learning Research –
|
Media
Successful Development of Pathology AI to Classify Suspected Urothelial Carcinoma Lesions – Published in Cancers / Special Issue: Artificial Intelligence in Cancer Screening –
|
Media
【Successful Development of Pathology AI】Now Possible to Classify Gastric Poorly Differentiated Adenocarcinoma – Published in “Technology in Cancer Research & Treatment”
|
News
PidPort crossed the ocean and was introduced to international participants at Arab Health 2023
|
News
Our CEO Iizuka Osamu accompanied Mr. Nishimura Yasutoshi, Minister of Economy, Trade and Industry, to the UAE and participated in the ministerial meeting for signing “the Japan-UAE Coordination Scheme for Advanced Technology (JU-CAT)”.
|
News
【Announcement of Exhibition Participation】 Arab Health 2023
|
Media
【Successful Development of Pathology AI】Now Possible for Highly Accurate Detection of Adenocarcinoma in Multiple Organs – Published in PLOS ONE
|
News
Osamu Iizuka, CEO of Medmain Inc., exchanged opinions with the US Ambassador to Japan Rahm Emanuel!
|
News
Notice of New Year Holidays
|
Media
【Successful Development of Pathology AI】Now Possible for Highly Accurate Detection of Prostate Cancer – Published in Cancers / Special Issue: Artificial Intelligence in Oncology –
|
Media
Medmain Inc. Established a Capital and Business Alliance with PSP and Raised 300 Million Yen to Accelerate the Promotion of Digital Pathology.
|
News
【Selected for “NEDO Research and Development Start-up Support Project” in FY2022 – Medmain Inc.】
|
Media
【Successful Development of Pathological AI】Now Possible to Classify Prostate Cancer in Histopathological Whole Slide Images -Published in Diagnostics-
|
Media